A Multiple Dose Study of Grazoprevir (MK-5172) in Hepatitis C-Infected Participants (MK-5172-010)
Clinical trial NCT01537900 · COMPLETED
Trial details
- NCT number
- NCT01537900
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2014-07-31
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.